Posted on 02/11/2009 in Scientific Life Technologies has delivered a "strong" financial performance during the third quarter of 2009, it stated this week.
The firm announced that its non-generally accepted accounting principles revenue for the third quarter reached $805 million (488 million pounds).
This represents an increase of three per cent over the third-quarter revenue of $784 million reported during the same period of 2008.
Additionally, organic revenue grew by five per cent over the same period of the previous year, Life Technologies revealed.
Greg Lucier, chairman and chief executive officer of the company, stated: "We saw good demand for our products and services around the globe and began to receive the initial purchases emanating from the American Recovery and Reinvestment Act."
He added that the sale of its mass spectrometry joint venture to Danaher Corporation also went according to plan.
Last month, Life Technologies released the SOLiD 3 Plus System - an enhanced next-generation genomic analysis facility allowing researchers to achieve the performing of mainstream sequencing of personal genomes for personalised medicine.
Other news stories from 02/11/2009
Read more in the Zenopa News Archive
How this news is generated
|
